TickerFacts.

RenovoRx, Inc. (RNXT): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$10.97M
Year ended 2025-12-31
-$11.87M
Trailing 12 months to 2026-06-30
2020-12-31: -$3.53M2021-12-31: -$5.92M2022-12-31: -$8.81M2023-12-31: -$10.26M2024-12-31: -$9.12M2025-12-31: -$10.97M-$10.97M
2020-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$10.97Mn/m2026-03-30, From 2025-01-01
2024-12-31-$9.12Mn/m2026-03-30, From 2024-01-01
2023-12-31-$10.26Mn/m2025-04-01, From 2023-01-01
2022-12-31-$8.81Mn/m2024-04-01, From 2022-01-01
2021-12-31-$5.92Mn/m2023-03-31, From 2021-01-01
2020-12-31-$3.53Mn/a2022-03-30, From 2020-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
RenovoRx, Inc. (RNXT)2025-12-31-$10.97Mn/m
PetVivo Holdings, Inc. (PETV)2026-03-31-$6.11Mn/m
SeaStar Medical Holding Corp (ICU)2025-12-31-$13.60Mn/m
Sintx Technologies, Inc. (SINT)2025-12-31-$8.57Mn/m
Catheter Precision, Inc. (VTAK)2025-12-31-$8.30Mn/m
EBR Systems, Inc. (NONE.)2025-12-31-$53.19Mn/m
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31-$3.83Mn/m
Vycor Medical Inc (VYCO)2025-12-31-$13.5Kn/m
Co-Diagnostics, Inc. (CODX)2025-12-31-$29.14Mn/m

Compare RNXT, PETV, ICU, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗